•
Dec 31, 2023

Sanara MedTech Q4 2023 Earnings Report

Sanara MedTech reported its Q4 2023 results, highlighting strategic and operational milestones including the acquisition of key assets and the launch of new products.

Key Takeaways

Sanara MedTech Inc. reported increased net revenues driven by sales growth across all major product lines. The company continues to hire experienced sales managers to drive growth in new territories and expand product sales in existing accounts.

Achieved sales growth across all major product lines.

Continued hiring experienced and talented sales managers.

Focused on driving growth in new territories.

Worked to increase product sales in existing accounts and expand usage in new specialty areas.

Total Revenue
$17.7M
Previous year: $15.3M
+15.5%
EPS
-$0.03
Previous year: -$0.51
-94.1%
Gross Profit
$14.8M
Previous year: $12.9M
+14.4%
Cash and Equivalents
$5.15M
Previous year: $8.96M
-42.5%
Free Cash Flow
-$903K
Previous year: -$698K
+29.3%
Total Assets
$73.9M
Previous year: $61M
+21.0%

Sanara MedTech

Sanara MedTech

Sanara MedTech Revenue by Segment

Forward Guidance

Sanara MedTech Inc. is positioned for continued strong growth in 2024.

Revenue & Expenses

Visualization of income flow from segment revenue to net income